Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance.
Saved in:
| Title: | Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance. |
|---|---|
| Authors: | Wang J; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA., Wee Y; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, 110, Taiwan., Jacob T; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA., Rogers A; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Sorensen LK; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Brooks DM; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA., Gupta P; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA., Tay JKH; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Wilson EC; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Liu T; Department of Dermatology, University of Utah, Salt Lake City, UT, USA., Smith EA; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Gopal YNV; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McMahon M; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Holmen SL; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Department of Surgery, University of Utah, Salt Lake City, UT, USA., Judson-Torres RL; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Wolff RK; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA., Grossmann AH; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org.; Department of Pathology, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org.; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA. allie.grossmann@providence.org.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org. |
| Source: | Oncogene [Oncogene] 2026 Jun; Vol. 45 (23), pp. 2286-2298. Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42050077 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rapid activation of ARF6 after RAF inhibition augments BRAF<superscript>V600E</superscript> and promotes therapy resistance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Wee+Y%22">Wee Y</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, 110, Taiwan.<br /><searchLink fieldCode="AU" term="%22Jacob+T%22">Jacob T</searchLink>; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Rogers+A%22">Rogers A</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Sorensen+LK%22">Sorensen LK</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Brooks+DM%22">Brooks DM</searchLink>; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+P%22">Gupta P</searchLink>; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Tay+JKH%22">Tay JKH</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+EC%22">Wilson EC</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Liu+T%22">Liu T</searchLink>; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Smith+EA%22">Smith EA</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Gopal+YNV%22">Gopal YNV</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Davies+MA%22">Davies MA</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22McMahon+M%22">McMahon M</searchLink>; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Holmen+SL%22">Holmen SL</searchLink>; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Department of Surgery, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Judson-Torres+RL%22">Judson-Torres RL</searchLink>; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA.; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Wolff+RK%22">Wolff RK</searchLink>; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Grossmann+AH%22">Grossmann AH</searchLink>; Department of Oncologic Sciences, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org.; Department of Pathology, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org.; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR, USA. allie.grossmann@providence.org.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. allie.grossmann@providence.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2026 Jun; Vol. 45 (23), pp. 2286-2298. <i>Date of Electronic Publication: </i>2026 Apr 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42050077 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41388-026-03805-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2286 Titles: – TitleFull: Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Wee Y – PersonEntity: Name: NameFull: Jacob T – PersonEntity: Name: NameFull: Rogers A – PersonEntity: Name: NameFull: Sorensen LK – PersonEntity: Name: NameFull: Brooks DM – PersonEntity: Name: NameFull: Gupta P – PersonEntity: Name: NameFull: Tay JKH – PersonEntity: Name: NameFull: Wilson EC – PersonEntity: Name: NameFull: Liu T – PersonEntity: Name: NameFull: Smith EA – PersonEntity: Name: NameFull: Gopal YNV – PersonEntity: Name: NameFull: Davies MA – PersonEntity: Name: NameFull: McMahon M – PersonEntity: Name: NameFull: Holmen SL – PersonEntity: Name: NameFull: Judson-Torres RL – PersonEntity: Name: NameFull: Wolff RK – PersonEntity: Name: NameFull: Grossmann AH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5594 Numbering: – Type: volume Value: 45 – Type: issue Value: 23 Titles: – TitleFull: Oncogene Type: main |
| ResultId | 1 |